Cuyàs, B, Alvarado-Tapias, E, Tan, EH, Golozar, A, Duarte-Salles, T, Delmestri, A, Argemi, J, Man, WY, Burn, E, Guarner-Argente, C, Alhambra, DP, Newby, D. Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021). EUROPEAN JOURNAL OF PUBLIC HEALTH. 2026; 36(2)DOI:10.1093/eurpub/ckaf153. PMID:41212072. IF:3.900(Q1/2D).

Rosales, A, Mendoza, L, Minambres, I. Strategies for the prevention and non-pharmacological treatment of obesity. Models of care. Atencion Primaria. 2024; 56(11)DOI:10.1016/j.aprim.2024.102978. PMID:38820670. IF:1.600(Q2/4D).

Blanco-Carrasco, AJ, Merino-Torres, JF, Almanza, MR, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, de Isla, LP, González, JFN. Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112214. PMID:40319920. IF:7.400(Q1/1D).

Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecub, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026). Jmir Research Protocols. 2026; 15DOI:10.2196/95267. PMID:. IF:(Q/D).

Collantoni, E, Miranda-Olivos, R, Ugur, S, Baenas, I, Tovar, S, Dieguez, C, Vilarrasa, N, Lopez-Urdiales, R, Guerrero-Pérez, F, Jiménez-Murcia, S, Soriano-Mas, C, Fernández-Aranda, F. Deciphering the association between morphological differences in hypothalamic subregions and circulating ghrelin and leptin concentrations: exploratory evidence in anorexia nervosa and obesity. Translational Psychiatry. 2025; 15(1)DOI:10.1038/s41398-025-03708-6. PMID:41253760. IF:6.200(Q1/1D).

Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecube, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study. Jmir Research Protocols. 2026; 15DOI:10.2196/85375. PMID:41734338. IF:(Q/D).

Perea, V, Quirós, C, Herrera-Arranz, MT, Azriel-Mira, S, Wägner, AM, Beato-Vibora, P, Soldevila, B, Barquiel, B, Pardo, RM, Díaz-Soto, G, Picón, MJ, Colomo, N, Amigó, J, Climent, E, Durán-Martínez, M, Corcoy, R, Codina, M, Cuesta, M, Guedes, BV, Vinagre, I. Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study. ACTA DIABETOLOGICA. 2025; 62(7)DOI:10.1007/s00592-024-02430-x. PMID:39630235. IF:2.900(Q3/6D).

Gil-Millan, P, Gimeno-Orna, JA, Rodriguez-Padial, L, Muniz, J, Barrios, V, Anguita, M, Perez, A. HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02995-z. PMID:41185008. IF:10.600(Q1/1D).

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Canones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis. Gastroenterologia y Hepatologia. 2025; 48(8)DOI:10.1016/j.gastrohep.2025.502442. PMID:40221023. IF:1.900(Q3/7D).

Orozco-Beltran, D, Mata-Cases, M, Artola-Menéndez, S, Alvarez-Guisasola, F, Cebrián-Cuenca, A, Pérez, A. Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care. Primary Care Diabetes. 2025; 19(1)DOI:10.1016/j.pcd.2024.12.002. PMID:39741072. IF:2.300(Q2/5D).

Meek, CL, Feig, DS, Scott, EM, Corcoy, R, Murphy, HR, CONCEPTT Collaborat Grp. Lack of Validity of the Glucose Management Indicator in Type 1 Diabetes in Pregnancy. DIABETES CARE. 2025; 48(8)DOI:10.2337/dc24-2494. PMID:40173096. IF:16.600(Q1/1D).

Magaz, M, Giudicelli-Lett, H, Abraldes, JG, Nicoara-Farcau, O, Turon, F, Rajoriya, N, Goel, A, Raymenants, K, Hillaire, S, Téllez, L, Elkrief, L, Procopet, B, Orts, L, Nery, F, Shukla, A, Larrue, H, Degroote, H, Aguilera, V, Llop, E, Turco, L, Indulti, F, Gioia, S, Tosetti, G, Bitto, N, Becchetti, C, Alvarado, E, Roig, C, Diaz, R, Praktiknjo, M, Konicek, AL, Olivas, P, Fortea, JI, Masnou, H, Puente, A, Ardèvol, A, Navascués, CA, Romero-Gutiérrez, M, Scheiner, B, Semmler, G, Mandorfer, M, Damiao, F, Baiges, A, Ojeda, A, Simón-Talero, M, González-Alayón, C, Díaz, A, García-Criado, A, De Gottardi, A, Hernández-Guerra, M, Genescà, J, Drilhon, N, Ferreira, CN, Reiberger, T, Rodríguez, M, Morillas, RM, Crespo, J, Trebicka, J, Bañares, R, Villanueva, C, Berzigotti, A, Primignani, M, La Mura, V, Riggio, O, Schepis, F, Verhelst, X, Calleja, JL, Bureau, C, Albillos, A, Nevens, F, Hernández-Gea, V, Tripathi, D, Rautou, PE, García-Pagán, JC. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome. JOURNAL OF HEPATOLOGY. 2025; 82(1)DOI:10.1016/j.jhep.2024.07.035. PMID:39181213. IF:33.000(Q1/1D).

Paternostro, R, Kwanten, WJ, Hofer, BS, Semmler, G, Bagdadi, A, Luzko, I, Hernández-Gea, V, Graupera, I, García-Pagán, JC, Saltini, D, Indulti, F, Schepis, F, Moga, L, Rautou, PE, Llop, E, Téllez, L, Albillos, A, Fortea, JI, Puente, A, Tosetti, G, Primignani, M, Zipprich, A, Vuille-Lessard, E, Berzigotti, A, Taru, MG, Taru, V, Procopet, B, Jansen, C, Praktiknjo, M, Gu, WY, Trebicka, J, Ibanez-Samaniego, L, Bañares, R, Rivera-Esteban, J, Pericas, JM, Genesca, J, Alvarado, E, Villanueva, C, Larrue, H, Bureau, C, Laleman, W, Ardevol, A, Masnou, H, Vanwolleghem, T, Trauner, M, Mandorfer, M, Francque, S, Reiberger, T. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD. JOURNAL OF HEPATOLOGY. 2024; 81(5)DOI:10.1016/j.jhep.2024.05.033. PMID:38823501. IF:33.000(Q1/1D).

Ukashi, O, Amiot, A, Laharie, D, Menchen, L, Gutierrez, A, Fernandes, S, Pessarelli, T, Correia, F, Gonzalez-Munoza, C, Lopez-Cardona, J, Calabrese, G, Ferreiro-Iglesias, R, Tamir-Degabli, N, Dussias, NK, Mousa, A, Oliveira, R, Richard, N, Veisman, I, Sharif, K, Ben-Horin, S, Soutullo-Castineiras, C, Dragoni, G, Rotulo, S, Favale, A, Calmejane, L, Bazin, T, Elosua, A, Lopes, S, Felice, C, Mauriz, V, Rodrigues, IC, Jougon, J, Botto, I, de Sousa, HT, Bertani, L, Abadia, PR, De Bernardi, A, Zabana, Y, Serra-Ruiz, X, Viola, A, Acosta, MBD, Yanai, H, Armuzzi, A, Magro, F, Kopylov, U. Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study. United European Gastroenterology Journal. 2025; 13(5)DOI:10.1002/ueg2.12757. PMID:39825768. IF:6.700(Q1/2D).

Llao, J, Mañosa, M, Martín-Arranz, E, Zabana, Y, Navarro-Llavat, M, Téller, M, Garcia-Planella, E, Busquets, D, Monfort, D, Pineda, JR, Gutiérrez, A, Villoria, A, Menchén, L, Bastida, G, García-Alonso, FJ, Rivero, M, Chaparro, M, de Francisco, R, Merino, O, Rodríguez-Lago, I, Acosta, MBD, Rodríguez-Fortúnez, P, Rodríguez-Jiménez, C, Calafat, M, Domènech, E. Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU. Journal of Crohns & Colitis. 2025; 19(11)DOI:10.1093/ecco-jcc/jjaf182. PMID:41258993. IF:8.700(Q1/1D).

Sánchez-Torrijos, Y, Torres-Domínguez, A, Carmona, I, Ibáñez-Samaniego, L, Román, E, Casado, M, García-Cortés, M, Jimeno, C, Rosales-Zabal, JM, Fernández-Alvarez, P, Sendra, C, López-Garrido, A, Ballester, MP, Rodríguez-Perálvarez, M, Estévez, M, García-García, A, Jiménez-Pérez, M, del Pino, P, Santamaría, G, Sánchez, J, Zamora, J, Rodríguez, M, Castillo, L, Aguilera, V, Romero, G, Reddy, KR, Romero-Gómez, M, Ampuero, J. REACT Score, a Novel Scoring System, Improves the Prediction of Non-Elective Readmissions in Patients With Decompensated Cirrhosis. LIVER INTERNATIONAL. 2026; 46(5)DOI:10.1111/liv.70639. PMID:41981917. IF:5.200(Q1/2D).

Coll-Vinent, B, Borràs, A, Escorsell, A, Comas, C. Closing the sex and gender gap in clinical practice: recommendations from the Catalan Society of Health with a Sex and Gender Perspective. The GENDERCARE decalogue. European Journal of Emergency Medicine. 2026; 33(2)DOI:10.1097/MEJ.0000000000001312. PMID:41557155. IF:4.200(Q1/1D).

Villanueva, CL, Arbizu, EA, Goruppi, I, Lozano, NB, Bianchi, F, Martínez, AP, Pina, SM, Caballero, AYM, Murzi, M, Betroletti, F, Estremera, F, Guerrero, SB, Argente, CG. Peroral endoscopic myotomy (POEM) as a treatment for pediatric achalasia: multicenter study and first results. Gastroenterologia y Hepatologia. 2025; 48(4)DOI:10.1016/j.gastrohep.2024.502262. PMID:39343296. IF:1.900(Q3/7D).

Scaramella, L, Cosenza, A, Romero-Mascarell, C, Elli, L. Antithrombotic and management of small bowel bleeding - time to throw caution into the wind?. CURRENT OPINION IN GASTROENTEROLOGY. 2026; 42(3)DOI:10.1097/MOG.0000000000001160. PMID:41700996. IF:2.500(Q2/5D).

Asmarats, L, Millan, X, Cubero-Gallego, H, Valverde, J, Li, CH, Arzamendia, D. Implementing a fast-track TAVI pathway in times of COVID-19: necessity or opportunity?. REC, interventional cardiology. 2022; 4(2)DOI:10.24875/RECICE.M22000269. PMID:. IF:(Q/D).